International Scholarly Research Notices / 2011 / Article / Tab 4

Clinical Study

Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm?

Table 4

Clinical, epidemiological, and therapeutic characteristics of 148 patients with differentiated thyroid carcinoma who received a therapeutic dose of radioactive iodine and showed another postiodine malignancy or not.

Clinical and epidemiological dataAnother postradioactive iodine malignancyOdds ratioIC 95%P
Yes
𝑁 = 7
(4.7%)
No
𝑁 = 1 4 1 (95.3%)

Males N (%)4 (57.1)21 (14.9)0.1230.015–1.0260.0528
Age at thyroidectomy (years)* 6 1 ± 1 7 4 4 . 0 8 ± 1 4 . 2 1.1331.0361.2390.0061
Follow-up period (months)**75 (48; 336)74 (9; 468)1.0131.000–1.0260.0514
Accumulated dose of 131I (mCi)**175 (100; 300)200 (30; 870)0.9940.985–1.0020.1375
Classic nonpapilliferous histological type N (%)3 (42.8)59 (41.8)2.3500.311–17.7420.4073

*mean ± standard deviation; **median (minimum value; maximum value).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.